Overall, the Greek healthcare system offers high-quality care to people living with diabetes (PwD). All types of insulin and supplies are fully reimbursed by the national insurance for people living with Type 1 diabetes (T1D). For people living with Type 2 diabetes (T2D), diabetes medicines and other medicines (such as those for cardiovascular diseases) are reimbursed at 90% and 75% of their cost respectively. Supplies such as test strips, needles and lancets are also fully reimbursed for people with T2D, but in lower quantities per month, depending on treatment. While CGMs are fully reimbursed for people with T1D, national diabetes associations are advocating to extend their reimbursement to people with T2D on intensified insulin therapy.

There is no formal education for specialist nurses in diabetes. However, some nurses working in diabetes centres have informal knowledge of diabetes care, and the Hellenic Diabetes Association is planning on creating a formal curriculum for diabetes educators.

The main gaps in diabetes care in Greece include the lack of specialised training for nurses and other HCPs, the absence of a diabetes registry, and the implementation of effective prevention programmes.

Watch the video testimonials from Prof. George Dimitriadis, Dimitris Kaperdanakis and Konstantina Boumaki, and read the written testimonial by Vasiliki Avrampou.

This country profile was developed with the help of the Hellenic Diabetes Association and Yourah network in Greece.